Avantor, Inc. (AVTR)
15.53
-0.09
(-0.58%)
USD |
NYSE |
Nov 13, 16:00
15.53
0.00 (0.00%)
After-Hours: 19:59
Avantor Enterprise Value : 13.81B for Nov. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 13.81B |
| November 11, 2026 | 13.88B |
| November 10, 2026 | 13.77B |
| November 09, 2026 | 14.00B |
| November 06, 2026 | 13.70B |
| November 05, 2026 | 13.48B |
| November 04, 2026 | 13.83B |
| November 03, 2026 | 13.78B |
| November 02, 2026 | 13.80B |
| October 30, 2026 | 14.10B |
| October 29, 2026 | 14.52B |
| October 28, 2026 | 14.53B |
| October 27, 2026 | 14.83B |
| October 26, 2026 | 14.94B |
| October 23, 2026 | 14.94B |
| October 22, 2026 | 14.84B |
| October 21, 2026 | 14.92B |
| October 20, 2026 | 14.48B |
| October 19, 2026 | 14.26B |
| October 16, 2026 | 14.35B |
| October 15, 2026 | 14.12B |
| October 14, 2026 | 13.86B |
| October 13, 2026 | 13.76B |
| October 12, 2026 | 13.72B |
| October 09, 2026 | 13.84B |
| Date | Value |
|---|---|
| October 08, 2026 | 13.65B |
| October 07, 2026 | 13.62B |
| October 06, 2026 | 13.68B |
| October 05, 2026 | 13.93B |
| October 02, 2026 | 13.62B |
| October 01, 2026 | 13.41B |
| September 30, 2026 | 13.42B |
| September 29, 2026 | 13.70B |
| September 28, 2026 | 13.73B |
| September 25, 2026 | 13.71B |
| September 24, 2026 | 13.80B |
| September 23, 2026 | 13.38B |
| September 22, 2026 | 13.50B |
| September 21, 2026 | 13.61B |
| September 18, 2026 | 13.89B |
| September 17, 2026 | 14.12B |
| September 16, 2026 | 13.95B |
| September 15, 2026 | 13.84B |
| September 14, 2026 | 13.65B |
| September 11, 2026 | 13.41B |
| September 10, 2026 | 13.46B |
| September 09, 2026 | 13.46B |
| September 08, 2026 | 13.71B |
| September 04, 2026 | 13.52B |
| September 03, 2026 | 13.67B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Champions Oncology, Inc. | 71.90M |
| Medpace Holdings, Inc. | 17.79B |
| Personalis, Inc. | 1.565B |
| Adaptive Biotechnologies Corp. | 4.881B |
| 10X Genomics, Inc. | 7.271B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 203.40M |
| Revenue (Quarterly) | 1.698B |
| Total Expenses (Quarterly) | 1.495B |
| EPS Diluted (Quarterly) | 0.2987 |
| Gross Profit Margin (Quarterly) | 31.49% |
| Profit Margin (Quarterly) | 11.98% |
| Earnings Yield | 3.19% |
| Operating Earnings Yield | 5.21% |
| Normalized Earnings Yield | 3.563 |